//-->   Home     News     Mutual Funds     Insurance     Markets      IPO       Forum       Contact Us

Markets Markets News Trading Calls BSE Indices NSE Indices Bulk Deals Weekly Gainers Weekly Losers BSE Replica BSE Announcements NSE Announcements    News All News    Mutual Fund MF News Recent Dividends Top Equity Funds Top Balanced Funds Mutual Fund FAQ    IPO IPO News Issues Open Now IPO Allotment Status    Insurance Life Insurance   Insurance News Look at assured sum when choosing life insurance products All you need to know about car insurance The Term Plan: Features and riders Fine print of claiming deduction on life insurance premium

Doctor Biotech Analysis: US healthcare stocks face obstacles after 2011 run Reuters A rebounding US economy could lead patients to resume doctor visits and elective procedures they had been putting off, which would benefit medical device makers, drug companies and healthcare providers such as hospitals. But that trend may take a while ... Medgenics' Disruptive Biotechnology Is One To Watch Seeking Alpha When you are diagnosed with anemia, you go to your doctor. Your doctor is going to tell you that you have an abnormally low hemoglobin count and he will prescribe an epogen shot to get your hemoglobin into check and into a 10-12 count range which is ... Los Angeles Times Patrick Soon-Shiong intends to take part in bid for Dodgers Los Angeles Times Soon-Shiong is a doctor, biotech investor and philanthropist. Forbes estimated his net worth at $7 billion in September. Frank McCourt, the Dodgers' outgoing owner, expects the team to sell for at least $1.5 billion. Patrick Soon - Shiong. and more » Biotech Dealmaking Gets Off to a Strong Start in 2012 MarketWatch (press release) The deal reflects Roche's efforts to build itself into a personalized medicine powerhouse and its belief that sequencing technology will eventually migrate from the lab to the doctor's office. Not counting the Roche-Illumina deal, life sciences ... and more » With Progress on Debt Accord, Greece Scrambles to Cut Pharma Costs Genetic Engineering News Needing an excuse for the continued overspending on drugs, Loverdos and Greece have found one in the nation's doctors, who he says continued to prescribe more "when they should have been prescribing less,” resulting in the cash-strapped government ... and more » VIASPACE Director Purchases Additional 4 Million Shares of Common Stock on the ... MarketWatch (press release) I am a medical doctor and board-certified radiation oncologist in my 25th year of private practice. I choose to pick my own investments rather than having someone else do that for me. Through the years, I have invested in numerous biotech companies: ... and more » Doctor looks at skin disease link Canada.com Centocor Ortho Biotech Service, the maker of a class of drugs known as biologics, used to treat difficult psoriasis cases, is conducting a far-reaching study to fill some of the gaps. Weichert invited a small number of her psoriasis patients to take ... BioMolded Products, LLC Opens Medical Consumables Manufacturing Facility MarketWatch (press release) "The LiquidBiopsy blood sample collection kit can be shipped unrefrigerated from the doctor's office to the processing lab, which greatly simplifies logistics for diagnostic companies," said Andre de Fusco, Cynvenio's CEO. "We have leveraged BioMolded ... and more » Patients May Die When Doctors Moonlight as Big Pharma's "Key Opinion Leaders" Care2.com (blog) A group of board-certified doctors greeted each other in a private room at a luxury hotel in California. The oncologists were big buyers of an anti-anemia drug called Procrit, sold by Ortho Biotech, a Johnson & Johnson (J&J) division. and more »

//-->

List 1   |   List 2   |   List 3   |   List 4   |   List 5   |   List 6   |   List 7   |   List 8   |   List 9   |   List 10   |   List 11   |   List 12   |   List 13

	DISCLAIMER: The views and investment tips expressed on marketsbull.com are on the basics of market study. marketsbull.com is not responsible for any losses that could occur due to this information, and advises users to check with certified experts before taking any investment decision. marketsbull.com does not guarantee the accuracy, adequacy or completeness...